“Current nutritional and pharmacological anti‑aging interventions”
Reviews how dietary strategies (caloric restriction, intermittent fasting, time‑restricted feeding, restriction of certain nutrients, phytochemicals) and pharmacological agents (senolytics, telomere modulators, etc.) can act on nutrient‑sensing, damage accumulation, and longevity pathways.
“Emerging Anti‑Aging Strategies — Scientific Basis and Efficacy”
Discusses newer interventions: boosting autophagy, clearing senescent cells, young plasma therapies, exercise, neurogenesis enhancement, antioxidants, stem cell therapy, etc.
“Targeting aging pathways with natural compounds: a review of curcumin, epigallocatechin gallate, thymoquinone, and resveratrol”
Covers how natural (plant) compounds act on aging pathways: anti‑oxidant, anti‑inflammatory, mitochondrial, sirtuin, etc.
“Effects of anti‑aging interventions on intestinal microbiota”
Focuses on how diet, exercise, drugs, and probiotics influence the gut microbiome and how that in turn can impact aging, inflammation, metabolic health.
“Sarcopenia and the biological determinants of aging: A narrative review from a geroscience perspective”
Looks at how muscle loss (sarcopenia) is tied to aging hallmarks: mitochondrial dysfunction, nutrient sensing, intercellular signaling, energy imbalance.
Surveys the potential and challenges of using stem cells (or stem cell derived therapies) to mitigate aging in tissues and organs
“Improving the effectiveness of anti‑aging modalities by using the constrained disorder principle‑based management algorithms”
Proposes using systems/algorithmic approaches (drawing from control theory) to guide anti‑aging interventions more adaptively
“The evolution of asymmetrical regulation of physiology is central to aging”
A theoretical / evolutionary model arguing that physiological regulation inherently becomes asymmetric (“drift”) with age, guiding how aging emerges over time.
“An evolutionary medicine and life history perspective on aging and disease: Trade‑offs, hyperfunction, and mismatch”
Applies evolutionary & life history theory to understand how growth/maintenance trade‑offs, hyperfunction (overactive pathways), and modern environmental mismatches drive aging.
“Critical dynamics of gene networks is a mechanism behind ageing and Gompertz law”
A quantitative / systems biology paper showing how gene regulatory networks’ instabilities and “critical dynamics” can generate aging-like mortality trajectories (Gompertz law).
“Biomarker Integration and Biosensor Technologies Enabling AI‑Driven Insights into Biological Aging”
Reviews biomarkers (CRP, IGF‑1, IL‑6, GDF15, etc.), sensor technologies, and AI methods for estimating biological age and guiding interventions.
“Gold Nanoparticles in Anti‑Aging Interventions: A Comprehensive Exploration of Skin Health and Cosmeceuticals”
Focuses on nanotechnology approaches (e.g. gold nanoparticles) in skin / cosmetic anti‑aging, mechanisms, safety issues.
“Geroprotective interventions converge on gene expression programs of reduced inflammation and restored fatty acid metabolism”
(From mice transcriptomic studies) Finds that different longevity interventions (senolysis, caloric restriction, parabiosis) share common molecular changes: suppression of inflammation, boosting lipid metabolism. (Discussed in commentary forums)
“The ageing epigenome and its rejuvenation”
Review on how epigenetic changes (DNA methylation, histone modifications, chromatin structure) evolve with age and how interventions aim to “rejuvenate” the epigenome. (Discussed in forums; original source in high‑impact journals)
“A complex systems approach to aging biology”
Argues for viewing aging not just as a molecular cascade but as emergent dysfunction in integrated regulatory networks, resilience, homeostasis, and interactions across scales.
